Lindahl acted as legal advisor to Corline Biomedical

Through the agreement, Imperative Care is given the exclusive right to use CHS™ in all types of neurovascular products given a certain level of compensation. Corline undertakes to supply CHS™-coated products according to defined specifications, but also to assist in further development and market registration of the current product. In addition, Corline will participate in the development of additional CHS™-coated products within the indication area. These products have the potential to generate revenue for Corline of approximately SEK 150 million per year and a total of more than SEK 1 billion.
Lindahl's team consisted of Hugo Norlén and Erika Svensson.
Corline's press release (in Swedish) is available here.
Do you want to know more? Contact:
Hugo Norlén
Partner | AdvokatErika Svensson
Partner | AdvokatCarousel items
-
Cases and transactions
6/30/2025
Lindahl advisor when Insig acquires residential portfolio in Nyköping
Insig AB has acquired four centrally located residential properties in Nyköping from Rikshem. Lindahl acted as legal advisor to Insig in the transaction. The agreed purchase price amounts to SEK 265 million, and completion is scheduled for 4 July...
-
News articles
6/27/2025
Johan Åberg appointed new Managing Partner at Lindahl in Stockholm
As of July 1, Advokatfirman Lindahl’s Stockholm office has a new Managing Partner. Johan Åberg succeeds Monica Lagercrantz, who has led the Stockholm office since January 2022.
-
Knowledge
6/27/2025
AB 04 and ABT 06 - Update on the BKK revision
After many years of work, the Construction Contracts Committee (BKK) is approaching the final phase of the comprehensive revision of the construction industry's standard contracts AB 04 and ABT 06. Here, Lindahl's experts review the latest status...
-
Portraits
6/23/2025
20 years at Lindahl: "It's a good grade, you develop all the time"
Johan Tollgerdt Ronnell has been part of Lindahl for almost 20 years. "It's a good mark, there have always been good and new career and development opportunities here."
-
Read more news and insights?